General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-20 | 2024-03 | -3.33 | -9.14 | -5.81 | -174.47% |
2024-04-02 | 2023-12 | -17.14 | N/A | N/A | N/A |
2023-11-14 | 2023-09 | -5.99 | N/A | N/A | N/A |
2023-11-14 | 2023-09 | -5.99 | -48.77 | -42.78 | -714.19% |
2023-08-14 | 2023-06 | -115.6 | -36.8 | 78.8 | 68.17% |
2023-08-14 | 2023-06 | -115.6 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-05 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-07-18 | ALBANNA AMRO A | Officer | 1.00 | Purchase |
2021-06-03 | ALBANNA ROWENA | Chief Operating Officer | 0.00 | Stock Award(Grant) |
2023-09-06 | BNP PARIBAS SECURITIES CORPORATION NORTH AMERICA | Unknown | 22.34K | Sale |
2021-05-25 | FARLEY THOMAS J | Officer | 2.50K | Purchase |
2020-07-21 | KIAIE NAMVAR | Director | 2.22K | Conversion of Exercise of derivative security |
2021-06-03 | PANKOVCIN CORINNE D | Chief Financial Officer | 169.22K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Sabby Management, LLC | 14.74K | 265.30K | 6.17% |
2023-06-29 | Vanguard Group Inc | 1.16K | 20.92K | 0.49% |
2023-09-29 | IFP Advisors, Inc | 1.08K | 13.53K | 0.45% |
2023-06-29 | State Street Corporation | 948.00 | 17.06K | 0.40% |
2023-06-29 | Natixis | 250.00 | 4.50K | 0.10% |
2023-06-29 | Tower Research Capital LLC (TRC) | 246.00 | 4.43K | 0.10% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 1.16K | 20.92K | 0.49% |
2023-05-30 | Fidelity Extended Market Index Fund | 39.00 | 951.00 | 0.02% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 44.00 | 1.07K | 0.02% |
2023-05-30 | Fidelity Series Total Market Index Fund | 18.00 | 439.00 | 0.01% |
Split | Date |
---|---|
1 : 40 | 2023-08-18 |
1 : 50 | 2022-09-14 |
1 : 50 | 2022-09-12 |
Xetnelav, please share you arguments. tks
Everybody has opinion but only a few really has studied this company. If you don’t believe on it, forget this stock. If you do, buy and hold. Simple as that. I will hold it for a long time. godd luck!
Andy, what are your arguments? how big short is your position. Please share your thoughts. tks
Andy, how short is you position?
Kroll, the AditxScore was already approved and started on 02/01/21, partnership with Salveo and Todos Medical. Could you please clarify your information? thank you
Stock Girl, Who are the analysts?
tks
Czar, where fid you get this information? tks
Andy, one day you will give to spend your time here. Be short im this stock and good luck. I am really, really long and I will wait more time without concern.
Queen go ahead shorting the stocks. Good luck
Andy you never give up and you insist to spend your time here.
Andy If you are write, stay in a high short position and don’t spend your time bothering us . Peace and good luck.
Guys, forget short sale. You must consider and believe on fundamentals.
Andy, you take the right decision, please don’t come back.
Trying to buy 100 shares atm pending wth
Hi Jason, sorry but what is the relation between your post and Adtx? Tkd
I have bought this stocks since last September and I have increased substantially my position. I trully believe its potential.
Hi Rob, I was not able to find anything on the adtix site about new issue of 10,5MM of new stocks. Could you please provide details? tks
$ADTX only reason this thing isn’t at 100% or more due to volume/float, but people are forgetting the 2386% turnover rate... bag holders, swing traders, and short positions being taken today is why we aren’t over 5$ plus rn, but still bullish for the EoD